Three Big Books

Saturday, April 20, 2019

Eight patients who took the popular HIV/AIDS drug Truvada and similar tenofovir-based drugs have sued Gilead Sciences, Inc., claiming the giant pharmaceutical company deliberately withheld a much safer version of these drugs from the market for more than a decade in a patent-timing scheme to maximize profits. As a result, "hundreds of thousands of HIV-infected patients experienced serious, permanent and sometimes fatal complications that may have been avoided had the company been honest about the safer alternative it had in the wings.

Mass Tort Alleges Gilead Sciences, Inc. Withheld Safer Drugs From HIV/AIDS Patients, Manipulated Patent Timing for Profit, Announces Jenner Law

Epidemiology is political.

Is the African-American community being harmed by toxic AIDS Drugs?

This ad campaign may be endangering the lives of millions of African-Americans.

Side Effects Of Truvada, Similar HIV Drugs, May Increase Risk Of HIV-Associated Neurocognitive Disorder: Study

More than half of HIV-positive patients taking medications like Truvada, Stribild and Atripla will eventually develop a neurocognitive disorder associated with the disease and the drug cocktails used to treat it, according to the findings of a new study.

Read about the man behind the disaster.

books on kindle

Two books on amazon

Everyone needs to know what the CDC is hiding about CFS and HHV-6. NEW YORK NATIVE contains both volumes of THE CHRONIC FATIGUE SYNDROME EPIDEMIC COVER-UP. The print version is $23. Only $7.98 in Kindle.

Popular Posts in the Last 7 Days

Our books on Amazon that are changing the way the world looks at CFS, HHV-6, and AIDS

Blog Archive

Closing Argument Audible

African Swine Fever Novel Audible

Stonewall Audible